A Two-part Healthy Volunteer Study to Investigate Both the Interaction of GSK2586184 With Rosuvastatin and Simvastatin and to Compare the Pharmacokinetics of Two Different Formulations of GSK2586184
Phase of Trial: Phase I
Latest Information Update: 22 May 2017
Price : $35 *
At a glance
- Drugs Solcitinib (Primary) ; Rosuvastatin; Simvastatin
- Indications Systemic lupus erythematosus
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 29 May 2014 According to the ClinicalTrials.gov record, status changed from recruiting to completed.
- 10 Oct 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 09 Oct 2013 New trial record